Overcoming Challenges with Amorphous Materials during Micronization

Our experts Fergus Manford, Matthew Green and David Thomas shared their knowledge about micronization in an article “Overcoming Challenges with Amorphous Materials during Micronization”, published by Pharmaceutical Outsourcing.

The team highlight the benefits of this technique affirming “There are two major benefits from reducing the size of the particle in a pharmaceutical product: firstly, broader ranges of target sites are available; and secondly, smaller particle size results in an increase in the surface area and this facilitates improved clinical efficacy.”

You can read the article “Overcoming Challenges with Amorphous Materials during Micronization” here.